Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Selective Intra-Arterial Yttrium-90 Radioembolization for the Treatment of Unresectable Pancreatic Adenocarcinoma: A Phase I Clinical Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07898683
Title field or adapter rule
{'original_value': 'Selective Intra-Arterial Yttrium-90 Radioembolization for the Treatment of Unresectable Pancreatic Adenocarcinoma: A Phase I Clinical Trial', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:21.882831+00:00
Published At
2026-10-27T00:00:00+00:00
Record Updated At
2026-10-27
Source Retrieved At
2026-10-31T22:17:25.750886+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pancreatic Cancer Non-resectable"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-27", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07898683"
protocolSection.identificationModule.officialTitle
"Selective Intra-Arterial Yttrium-90 Radioembolization for the Treatment of Unresectable Pancreatic Adenocarcinoma: A Phase I Clinical Trial"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Pancreatic Cancer Non-resectable (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'description': 'Selective intra-arterial infusion of Yttrium-90 (90Y) glass microspheres into the pancreatic tumor via catheterization of tumor-feeding arteries. The intervention involves pre-treatment dosimetry planning using 99mTc-MAA SPECT/CT, followed by sequential dose escalation of 90Y activity corresponding to absorbed doses. Post-therapy imaging (SPECT/CT) will be performed to assess microsphere distribution and radiation dosimetry.', 'name': 'Transarterial Radioembolization', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.